- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03521622
Effectiveness of Counseling Interventions to Modify Risk Behaviors in Patients at the Hospital San Ignacio. (EFICO)
March 12, 2024 updated by: Hospital Universitario San Ignacio
Effectiveness of Counseling Interventions to Modify the Stage of Behavioral Change in Risk Behaviors (Smoking and Risky Alcohol Consumption) of Patient's Candidates for Surgery at the Hospital San Ignacio. Bogotá-Colombia
Randomized clinical trial that aims to determine the effectiveness of a counseling intervention to modify the stage of behavioral change in risk behaviors (smoking and risky alcohol consumption) in patients candidates for scheduled surgery or diagnostic procedures at the Hospital Universitario de San Ignacio.
Bogotá-Colombia
Study Overview
Detailed Description
Objective: to determine the effect in the behavioral change stage of an intervention to modify risk behaviors (smoking and risky alcohol consumption) in patients candidates for scheduled surgery or diagnostic procedures at the Hospital Universitario de San Ignacio.
Design: controlled clinical trial with random assignment Population: patients candidates for scheduled surgery or diagnostic procedures in surgery rooms between 19 and 64 years attending the pre-anesthetic consultation of the Hospital Universitario de San Ignacio.
Interventions: brief behavioral intervention to modify risk behaviors versus information material on healthy lifestyles.
Measurements: the characteristics of the study population will be described and the intervention and control groups will be compared in their basic conditions.
The level of advance in the stage of change in the intervention and control arm, the proportion of people with the presence of the risk factor, as well as the decrease in the consumption of tobacco and alcohol will be compared.
Expected duration: 28 months.
Financing: Hospital Universitario de San Ignacio and Pontificia Universidad Javeriana.
Ethical aspects: the study is adjusted to international and national standards for research projects.
Under this norm, it is classified in the category of minimum risk because it is a clinical experiment with a common intervention in clinical practice.
Study Type
Interventional
Enrollment (Actual)
440
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Distrito Capital
-
Bogotá, Distrito Capital, Colombia
- Hospital Universitario de San Ignacio
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 64 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- candidates for scheduled surgery with a hospital stay of 3 days or less (including ambulatory surgeries) or who attend outpatient diagnostic procedures performed in surgery rooms.
- Current smokers (any tobacco product in the last month and more than 100 cigarretes in life) or risky alcohol drinkers (more than 4 or 5 alcohol standard drinks during the last year and AUDIT score between 8-15 points)
- patients with contact information
- Patients that want to participate
Exclusion Criteria:
- People who are being treated for smoking cessation or decreased consumption of alcohol.
- People with diseases that compromise their ability to understand information or their ability to verbal communication
- Patients with dependence or abuse of alcohol or other psychoactive substances other than tobacco
- Patients in action or maintenance stages of behavioral change against their risk factor
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: brief counseling interventions
For smoking patients the brief intervention is 5 As model for motivated patients and 5Rs for not motivated patients. For risky alcohol drinkers the brief intervention is simple advise for motivated patients and brief intervention for not motivated patients. |
Brief counseling for motivated smoker 5 As model Brief counseling for not motivated smokers 5 Rs model Brief counseling for motivated risky drinkers simple advice Brief counseling for not motivated risky drinkers brief alcohol intervention
|
|
Placebo Comparator: Control group
written informative material about healthy lifestyles
|
Brief counseling for motivated smoker 5 As model Brief counseling for not motivated smokers 5 Rs model Brief counseling for motivated risky drinkers simple advice Brief counseling for not motivated risky drinkers brief alcohol intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the level of progress in the stage of behavioral change
Time Frame: one and three months after the intervention
|
Stages of change of Prochaska and DiClemente
|
one and three months after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
proportion of smokers and risky alcohol drinker
Time Frame: one and three months after the intervention
|
proportion of smokers and risky alcohol drinker in each arm of the study
|
one and three months after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Luz H Alba, MD, Hospital San Ignacio
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ingrid A, Olaya L, Cuevas V, Castillo JS, Becerra N, Delgado J, Canas A, Alba LH. Effectiveness of brief counselling in a hospital setting for smoking cessation and risky alcohol drinking reduction: randomised clinical trial protocol. Rev Colomb Psiquiatr (Engl Ed). 2022 Apr-Jun;51(2):146-152. doi: 10.1016/j.rcpeng.2020.06.003. Epub 2022 Jun 16. English, Spanish.
- Almonacid I, Olaya L, Cuevas V, Castillo JS, Becerra N, Delgado J, Canas A, Alba LH. Effectiveness of Brief Counseling in a Hospital Setting for Smoking Cessation and Risky Alcohol Drinking Reduction: Randomized Clinical Trial Protocol. Rev Colomb Psiquiatr (Engl Ed). 2020 Nov 12:S0034-7450(20)30085-8. doi: 10.1016/j.rcp.2020.06.005. Online ahead of print. English, Spanish.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2018
Primary Completion (Actual)
May 30, 2019
Study Completion (Actual)
May 30, 2020
Study Registration Dates
First Submitted
April 30, 2018
First Submitted That Met QC Criteria
April 30, 2018
First Posted (Actual)
May 11, 2018
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 12, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2018/07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Behavior
-
Ohio State University Comprehensive Cancer CenterBreast Cancer Research FoundationRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingBehavior, RiskUnited States
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedRisk ReductionSouth Africa
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompleted
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustWithdrawnRisk Behavior | Violence | Risk Behavior, Health
-
University of California, San FranciscoUniversity of MiamiCompletedRisk ReductionUnited States
-
Hadassah Medical OrganizationHebrew University of JerusalemNot yet recruitingHealth Behavior | Food Habits | Lifestyle Risk Reduction
-
Hadassah Medical OrganizationCompletedHealth Behavior | Food Habits | Lifestyle Risk ReductionIsrael
-
Vivoptim SolutionsCompletedCardiovascular Risk | Lifestyle Risk Reduction | Cardiovascular Disease Prevention | Lifestyle (Sedentary Behavior and Physical Activity) | Health Behavior ChangeFrance
-
Istituto per la Ricerca e l'Innovazione BiomedicaFondazione Don Carlo Gnocchi Onlus; Universita degli Studi di Palermo; Medilink...RecruitingHealth Promotion | Life Style, Healthy | Risk ReductionItaly
Clinical Trials on brief counseling
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Obesity | Diabetes | Metabolic Syndrome | Hypercholesterolemia
-
Connecticut Children's Medical CenterCommunity Health NetworkCompleted
-
The University of Hong KongUnknown
-
VA Office of Research and DevelopmentCompleted
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
MicrolifeUnknownObesityUnited States
-
Prisma Health-UpstateNational Institute on Drug Abuse (NIDA)RecruitingTobacco-flavored EC | Sweet-Cooling EC | Sweet Non-cooling ECUnited States
-
University Medicine GreifswaldCompletedCardiovascular Risk Factor
-
Northwestern UniversityCompleted
-
Medical College of WisconsinActive, not recruitingHuman Immunodeficiency VirusUnited States